➀ Researchers at IISc developed a vanadium-based nanozyme to combat abnormal blood clotting by mimicking antioxidant enzymes and reducing reactive oxygen species (ROS) levels;

➁ The V₂O₅ nanozymes effectively suppressed platelet overactivation in human blood and reduced thrombosis in a mouse model of pulmonary thromboembolism (PTE) without harmful side effects;

➂ Unlike traditional antiplatelet drugs, the nanozymes modulate redox signaling without interfering with normal clotting, potentially reducing bleeding risks associated with current therapies.